Life sciences innovation, investment and impact were the focus for a major summit in Aberdeen, attracting sector leaders from across the UK.
More than 130 innovators and entrepreneurs, academics and researchers, clinicians and healthcare professionals, and venture capitalists and investors attended the summit, held in King’s College Conference Centre on 30 March.
The event was co-created and delivered through a partnership of The Times and Sunday Times Scotland, Opportunity North East and BioHub, and supported by the University of Aberdeen.
Keynotes, panel discussions and showcase sessions explored the latest biotech and healthtech developments, funding and investment for company growth, and what is coming next for this high-value sector regionally and nationally – including the opening of the transformational BioHub in Aberdeen later this year.
Speaking at the summit opening, ONE CEO Jennifer Craw said: “I hope you'll agree that the sector’s story of the past two years is one of extraordinary progress.
“The challenge ahead is to ensure that the ideas that are the foundations of your research and innovation can become solutions. Therapies, treatments, technologies that change people’s lives and deliver economic value.
“BioHub is now a real place moving into its late construction phase. Ready to become the focal point for life sciences company creation and growth, Providing the space and specialist support to new and scaling businesses, and connections to empowering networks and investors. It is a physical manifestation of the Aberdeen city region's confidence in life sciences and its role in our future, low-carbon economy.
“So today’s agenda of life sciences innovation, investment and impact is about and for you. The innovators and entrepreneurs, the clinicians and healthcare professionals, the venture capitalists and investors. And how together we can accelerate world-leading research and innovation.”
Key takeaways from the day were:
To sum up, Houman Ashrafian of SV Health Investors put it succinctly when he said: “Life sciences is unequivocally the most exciting sector in the UK commercial ecosystem today.”
A huge thank you goes to the speakers, delegates, organisers and partners who shared their insights, experiences and views, and collectively made the 2022 Life Sciences Summit such a positive and inspiring day. They included: Mark Bamforth, Arranta Bio; Dr Rabinder Buttar, formerly Clintec International; Dr Deborah O’Neil, Novabiotics; Dr Glenn Corr, TauRx; Dr James McIlroy, EnteroBiotix; Dr Tiffany Wood, Dyneval; Prof Andy Porter, Elasmogen/University of Aberdeen; Dee Dinneen, Kheiron Medical Technologies; Dr Ignat Drozdov, Bering; Dr Andrew Keen, NHS Grampian; Houman Ashrafian, SV Health Investors; Dr Martin Turner, UK Bioindustry Association; Struan Wilkie, NHS Grampian; Tom Whipple, The Times; Magnus Llewellin, The Times Scotland; Jason Allardyce, Sunday Times Scotland; and Jennifer Craw, Opportunity North East.
Your privacy matters to us so if you want to find out more on how we keep your data safe, view our Privacy Notice or talk to ONE direct.
Opportunity North East Ltd
11 Queens Gardens